Non allergic angioedema: Diagnosis and management;L'angio-œdème non allergique: Mise au point

Revue de Medecine Interne

Volumn 23, Issue 6, 2002, Pages 533-541

  Bouillet, L ^a   Ponard, D ^a   Drouet, C ^a   Massot, C ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Angioedema; Bradykinin; C1Inh

Indexed keywords

ANGIOTENSIN ANTAGONIST; BRADYKININ; COMPLEMENT COMPONENT C1S INHIBITOR; CYPROTERONE ACETATE; DIANE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; ETHINYLESTRADIOL; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PLASMIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANGIONEUROTIC EDEMA; COMPLEMENT SYSTEM; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EMOTION; FAMILIAL DISEASE; HUMAN; IDIOPATHIC DISEASE; KALLIKREIN KININ SYSTEM; ORAL CONTRACEPTION; PATHOPHYSIOLOGY; REVIEW; SOLAR RADIATION; VASCULITIS; ARTICLE; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; FEMALE; MALE; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; DIAGNOSIS, DIFFERENTIAL; ESTROGENS; FEMALE; HUMANS; MALE; PLASMIN; RISK FACTORS; SEX FACTORS;

EID: 2242489906     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00608-2     Document Type: Short Survey

References (56)

1. Angioedema due to angiotensin-converting enzyme inhibitors
2. A sensitive method to assay blood complement C1 inhibitor activity
3. C1 Inhibitor gene and hereditary angioedema
4. Biochemical abnormality in HANE: Absence of serum inhibitor C1 esterase
5. Activation of the coagulation cascade in C1Inh deficiencies
6. Plasma bradykinin in angio-eodema
7. Hereditary angioneurotic edema: Characterization of plasma kinin and vascular permeability-enhancing activities
8. Generation of plasmin during acute attacks of hereditary angioedema
9. Les angio-œdèmes par déficit en C1 Inhibiteur
10. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations
11. Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman
12. Hereditary angioedema
13. Treatment of hereditary angioedema with danazol
14. Danazol therapy: An unusual aetiology of hepatocellular carcinoma
15. Traitement par danazol, une étiologie exceptionnelle d'hépatocarcinome: À propos d'une observation
16. Tranexamic acid therapy in hereditary angioneurotic edema
17. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate
18. Acquired C1 esterase inhibitor deficiency
19. Acquired Clinhibitor deficiency with lymphoma causing recurrent angioedema
20. Evidence for immune complexes involving antilymphocyte antibodies associated with hypocomplementemia in chronic lymphocytic leukemia (CLL)
21. Waldenstr6m's macroglobulinemia with prominent splenomegaly and multiple immune disorders
22. L'œdème angioneurotique acquis: Caractéristiques cliniques et biologiques chez 9 patients
23. Angioedema and multiple myeloma
24. Acquired C1 inhibitor deficiency in essential cryoglobulinemia and macroglobulinemia
25. Acquired angioedema and hypocomplementemia in a patient with myelofibrosis. Effect of danazol treatment
26. Angioedema due to acquired C1 esterase inhibitor deficiency patient with helicobacter pylori infection
27. Acquired angioedema associated with chronic hepatitis C
28. Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia
29. Acquired deficiency of functional Clesterase inhibitor in VIH type 1 infected patients
30. Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus
31. A new type of acquired C1Inhibitor deficiency associated with systemic lupus erythematosus
32. An association between C1 esterase inhibitor deficiency and lupus erythematosus: Report of two cases and review of the literature
33. First case of acquired functional C1 INH deficiency: Association with angioedema during Churg and Strauss vasculits
34. Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol
35. Acquired deficiency in C1 inhibitor associated with signet ring cell gastric adenocarcinoma: A probable connection of antitumor associated antibodies, hemolytic anemia, and complement turnover
36. Autoimmune C1 inhibitor deficiency: Report of eight patients
37. Relevance of lymphoproliférative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-edema
38. C1-inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema
39. Acquired angioedema with C1 inhibitor deficiency: Is the distinction between type I and type II still relevant?
40. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid
41. Recurrent angioedema: Familial and estrogen induced
42. Recurrent angiooedema associated with hypogonadism or anti-androgen therapy
43. Pilule estroprogestative responsable d'angioœdèmes récidivants avec ou sans urticaire dans un contexte d'allergie alimentaire
44. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives
45. Familial carboxypeptidase N deficiency
46. Clinical, biochemical, and genetic characterization of a novel estrogen dependent inherited form of angioedema
47. Hereditary angioedema with normal C1 Inhibitor activity in women
48. Hereditary angioedema type III: An additional French pedigree with autosomal dominant transmission
49. Idiopathic non histaminergic angioedema
50. Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codein and histamine
51. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
52. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin converting enzyme inhibitor
53. Angioneurotic edema attributed to the use of losartan
54. Angioedema: Manifestations and management
55. Hypocomplementemic urticarial vasculitis syndrome
56. Episodic angioedema associated with eosinophilia